People Like Me
It’s good to hear from people going through similar things. Listen to these stories and then click on “Share my Story.” You might just see yourself on CF Living one day.
Sarah Y.
Fairlawn, NJ
18 years old
Life is about challenges and obstacles. Living with chronic illnesses can use one's strengths to help others. I am able to appreciate life and realize I have benefited from my illnesses and the many people who I have met that have added an extra dimension to my life.
Jeremy K.
Alameda, CA
18 years old
Watch a video about Jeremy as he talks about balancing life with his prescribed CF treatments.
Watch Jeremy’s Video ›
Indication and Usage
Daily administration of Pulmozyme® (dornase alfa) Inhalation Solution along with standard therapies is indicated in the management of cystic fibrosis patients to improve lung function. In patients with a forced vital capacity (volume of air exhaled with maximum effort and speed) greater than or equal to 40% of predicted, daily administration of Pulmozyme has also been shown to reduce the risk of respiratory tract infections requiring the administration of injectable antibiotics. In our pivotal study, safety and efficacy of daily administration has not been studied in patients beyond 12 months.
Important Safety Information
Pulmozyme should not be used in patients who are allergic to any of its
ingredients
Pulmozyme should be used along with standard therapies for cystic fibrosis
When starting Pulmozyme therapy, patients may experience change in or loss of their voice, discomfort in the throat, chest pain, red watery eyes, rash, dizziness, fever, or runny nose
These side effects are usually mild and short-lived
The effect of Pulmozyme on exercise tolerance has not been established in adults and children
For further information, please see the Pulmozyme full prescribing information. If you have questions, please discuss them with your CF healthcare team.
